loader
Please Wait
Applying Filters...
menu
    • menu

    Everything You Should Know About Cytotoxic Compound API Manufacturing for Selecting a Top CDMO / CMO What are Cytotoxic Compounds? Often we get questions coming up like what is cytotoxicity and how is it different from anticancer drugs and antioxidants. Some people even get asked whether there is any relation among these molecules and their pharmacological activities. This can be a pertinent question for situations when a scientist has just synthesized a specialized molecule like an indole-based

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    fermion wp

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Fermion Oy

    02 1Axplora

    03 1Minakem

    04 1Biophore India Pharmaceuticals Pvt Ltd

    05 1Aspen API

    06 1Aarti Pharmalabs

    07 1APC Ltd

    08 1Aurigene Pharmaceutical Services

    09 1Cerbios-Pharma SA

    10 1ChemCon GmbH

    11 1Curia

    12 1Dishman Carbogen Amcis

    13 1Eurofins CDMO

    14 1Fareva

    15 1Farmhispania

    16 1Indena

    17 1Mac-Chem Products (India) Pvt.Ltd

    18 1Pierre Fabre

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    Learn More #LearnMore
    price-trend Ask Us

    01

    Fermion Oy

    Flag Finland
    arrow
    Contract Pharma
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Fermion, start the journey of your innovative API.

    Pharma Service : API Manufacturing

    CYTOTOXIC API CONTRACT MANUFACTURING

    Fermion is a contract development and manufacturing organization (CDMO) with two USFDA and EMA approved API manufacturing sites for the commercial manufacturing of cytotoxic APIs, steroids and conventional molecules.

    arrow

    Category : Cytotoxic Compound

    Sub Category : Overview

    Pharma Service : API Manufacturing

    Cytotoxic API Contract Manufacturing

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    02

    Axplora

    Flag Germany
    arrow
    PREP
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothAxplora is your partner of choice for complex APIs.

    Pharma Service : API Manufacturing

    CONTRACT MANUFACTURING FOR CYTOTOXIC API...

    Axplora is a fast-growing CDMO that offers contract manufacturing of cytotoxic APIs. Its Gropello site in Italy has more than 30 years of experience in manufacturing and scaling up high-potency active pharmaceutical ingredients (HPAPIs) and cytotoxics.

    arrow

    Category : Cytotoxic Compound

    Sub Category : Overview

    Pharma Service : API Manufacturing

    CONTRACT MANUFACTURING FOR CYTOTOXIC APIs

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    03

    Minakem

    Flag France
    arrow
    CPhI WW Frankfurt
    Booth #6.0D14
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Pharma Service : API Manufacturing

    CYTOTOXIC COMPOUND MANUFACTURING

    Minakem offers manufacturing of cytotoxic and high potency compounds. It has expertise in certain technologies such as flow reactions, hazardous chemistry, HPAPIs (highly potent APIs), and low-temperature chemistry.

    arrow

    Category : Cytotoxic Compound

    Sub Category : Overview

    Pharma Service : API Manufacturing

    Cytotoxic Compound Manufacturing

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    04

    Biophore India Pharmaceuticals Pvt Ltd

    Flag India
    arrow
    CPhI WW Frankfurt
    Booth #9.1A6
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Pharma Service : API Manufacturing

    CONTRACT MANUFACTURING FOR ONCOLOGY APIs

    With a dedicated Oncology block at R&D as well as at the manufacturing plant, Biophore is capable of developing various anticancer APIs.

    arrow

    Category : Cytotoxic Compound

    Sub Category : Overview

    Pharma Service : API Manufacturing

    Biophore Contract Manufacturing for Oncology APIs

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    05

    Aspen API

    Flag Netherlands
    arrow
    Contract Pharma
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothAspen API. More than just an API™

    Pharma Service : API Manufacturing

    CYTOTOXIC API MANUFACTURING

    Aspen API has expertise in the manufacturing of cytotoxic APIs and high potency APIs (HPAPIs). Cytotoxic product manufacturing is carried out in its Fine Chemicals Corporation site for commercial manufacturing of batches ranging from 1 kg to 500 kg API.

    arrow

    Category : Cytotoxic Compound

    Sub Category : Overview

    Pharma Service : API Manufacturing

    Cytotoxic API Manufacturing

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    06

    Aarti Pharmalabs

    Flag India
    arrow
    BIOHK2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothAarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

    Pharma Service : API Manufacturing

    CDMO FOR CYTOTOXIC APIs

    Aarti Pharmalabs is involved in the contract development and manufacturing of high potency APIs including cytotoxic and anticancer compounds. It also offers the development and production of steroid APIs.

    arrow

    Category : Cytotoxic Compound

    Sub Category : Overview

    Pharma Service : API Manufacturing

    Aarti CDMO for Cytotoxic APIs

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    07

    Cerbios-Pharma SA

    CDMO FOR CYTOTOXIC COMPOUNDS

    arrow
    BIOHK2025
    Not Confirmed

    08

    Mac-Chem Products (India) Pvt.Ltd

    MANUFACTURING OF HIGHLY POTENT CYTOTOXIC...

    arrow
    BIOHK2025
    Not Confirmed

    09

    Pierre Fabre

    CYTOTOXIC COMPOUND MANUFACTURING

    arrow
    BIOHK2025
    Not Confirmed

    10

    Farmhispania

    CONTRACT MANUFACTURING OF CYTOTOXIC APIs

    arrow
    BIOHK2025
    Not Confirmed

    11

    ChemCon GmbH

    CYTOTOXIC API MANUFACTURING

    arrow
    BIOHK2025
    Not Confirmed

    12

    Dishman Carbogen Amcis

    CYTOTOXICS / CYTOSTATICS MANUFACTURING

    arrow
    BIOHK2025
    Not Confirmed

    13

    APC Ltd

    CYTOTOXIC COMPOUNDS

    arrow
    BIOHK2025
    Not Confirmed

    14

    Curia

    MANUFACTURING OF CYTOTOXIC COMPOUNDS

    arrow
    BIOHK2025
    Not Confirmed

    15

    Fareva

    CYTOTOXIC COMPOUND CDMO

    arrow
    BIOHK2025
    Not Confirmed

    16

    Aurigene Pharmaceutical Services

    CYTOTOXIC API CONTRACT MANUFACTURING

    arrow
    BIOHK2025
    Not Confirmed

    17

    Eurofins CDMO

    CYTOTOXIC COMPOUND MANUFACTURING

    arrow
    BIOHK2025
    Not Confirmed

    18

    Indena

    CYTOTOXIC COMPOUNDS

    arrow
    BIOHK2025
    Not Confirmed